Therapeutic potential of nicotinamide adenine dinucleotide (NAD)

被引:13
|
作者
Arenas-Jal, Marta [1 ,2 ]
Sune-Negre, J. M. [1 ]
Garcia-Montoya, Encarna [1 ]
机构
[1] Univ Barcelona, Pharm & Pharmaceut Technol Dept, Fac Pharm & Food Sci, Barcelona, Spain
[2] Autonomous Univ Barcelona, ICN2 Catalan Inst Nanosci & Nanotechnol, Bellaterra, Barcelona, Spain
关键词
NAD; Metabolism; Therapeutic potential; Drug discovery; Supplementation; FATTY LIVER-DISEASE; NLRP3; INFLAMMASOME; CISPLATIN OTOTOXICITY; CALORIC RESTRICTION; OXIDATIVE STRESS; CELL-SURVIVAL; LIFE-SPAN; METABOLISM; SIRT1; CD38;
D O I
10.1016/j.ejphar.2020.173158
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nicotinamide adenine nucleotide (NAD) is a small ubiquitous hydrophilic cofactor that participates in several aspects of cellular metabolism. As a coenzyme it has an essential role in the regulation of energetic metabolism, but it is also a cosubstrate for enzymes that regulate fundamental biological processes such as transcriptional regulation, signaling and DNA repairing among others. The fluctuation and oxidative state of NAD levels regulate the activity of these enzymes, which is translated into marked effects on cellular function. While alterations in NAD homeostasis are a common feature of different conditions and age-associated diseases, in general, increased NAD levels have been associated with beneficial health effects. Due to its therapeutic potential, the interest in this molecule has been renewed, and the regulation of NAD metabolism has become an attractive target for drug discovery. In fact, different approaches to replenish or increase NAD levels have been tested, including enhancement of biosynthesis and inhibition of NAD breakdown. Despite further research is needed, this review provides an overview and update on NAD metabolism, including the therapeutic potential of its regulation, as well as pharmacokinetics, safety, precautions and formulation challenges of NAD supplementation.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Therapeutic Potential of Nicotinamide Adenine Dinucleotide for Nonalcoholic Fatty Liver Disease
    Gual, Philippe
    Postic, Catherine
    HEPATOLOGY, 2016, 63 (04) : 1074 - 1077
  • [2] The effects of nicotinamide adenine dinucleotide in cardiovascular diseases: Molecular mechanisms, roles and therapeutic potential
    Zhang, Xiaokai
    Zhang, Yang
    Sun, Aijun
    Ge, Junbo
    GENES & DISEASES, 2022, 9 (04) : 959 - 972
  • [3] Nicotinamide adenine dinucleotide as a photocatalyst
    Kim, Jinhyun
    Lee, Sahng Ha
    Tieves, Florian
    Paul, Caroline E.
    Hollmann, Frank
    Park, Chan Beum
    SCIENCE ADVANCES, 2019, 5 (07):
  • [4] Automated assay for nicotinamide adenine dinucleotide (NAD+)
    Byers, S
    Anderson, D
    Brobst, D
    Cowan, F
    JOURNAL OF APPLIED TOXICOLOGY, 2000, 21 : S19 - S22
  • [5] Nicotinamide Adenine Dinucleotide (NAD+)-Dependent Signaling in Neurological Disorders
    Bresque, Mariana
    Esteve, Daniel
    Pehar, Mariana
    Vargas, Marcelo R.
    ANTIOXIDANTS & REDOX SIGNALING, 2023, 39 (16) : 1150 - 1166
  • [6] Viewing teratogens through the lens of nicotinamide adenine dinucleotide (NAD plus )
    Mark, Paul R.
    Dunwoodie, Sally L.
    BIRTH DEFECTS RESEARCH, 2022, 114 (20): : 1313 - 1323
  • [7] Can Nicotinamide Adenine Dinucleotide (NAD+) and Sirtuins Be Harnessed to Improve Mare Fertility?
    Pollard, Charley-Lea
    ANIMALS, 2024, 14 (02):
  • [8] Nicotinamide adenine dinucleotide homeostasis and signalling in heart disease: Pathophysiological implications and therapeutic potential
    Mericskay, Mathias
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2016, 109 (03) : 207 - 215
  • [9] Pharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors
    She, Jing
    Sheng, Rui
    Qin, Zheng-Hong
    AGING AND DISEASE, 2021, 12 (08): : 1879 - 1897
  • [10] Conformations of nicotinamide adenine dinucleotide (NAD+) in various environments
    Smith, PE
    Tanner, JJ
    JOURNAL OF MOLECULAR RECOGNITION, 2000, 13 (01) : 27 - 34